This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Navigate Market Turbulence With These 4 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Erie Indemnity (ERIE), TreeHouse (THS), HII (HII) and ADMA Biologics (ADMA) are well-poised to gain.
Is Erie Indemnity (ERIE) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Earnings Estimates Moving Higher for Erie Indemnity (ERIE): Time to Buy?
by Zacks Equity Research
Erie Indemnity (ERIE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Erie Indemnity (ERIE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 22.75% and 6.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
Erie Indemnity (ERIE) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 2.15% and 5.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Rallies 137.7% in a Year: More Room to Run?
by Zacks Equity Research
EverQuote (EVER) gains from reduced operating expenses, the enhancement of its platform via machine learning and artificial intelligence, and expected recovery in the auto insurance business.
Brown & Brown (BRO) Gains 34% in a Year: Will the Rally Last?
by Zacks Equity Research
Brown & Brown (BRO) stock rallies on the back of higher core commissions and fees, new business, strategic acquisitions, strong financial position and effective capital deployment.
Reasons Why Investors Should Retain Arthur J. Gallagher (AJG)
by Zacks Equity Research
Arthur J. Gallagher (AJG) is poised to gain from the solid performance of its Brokerage and Risk Management segments, strategic buyouts and optimistic growth projections.
Key Highlights From CNO Financial's (CNO) Optavise Report
by Zacks Equity Research
CNO Financial's (CNO) Annual Benefits Broker Survey highlights the growing requirements of broker partners to address employers' regulatory and compliance management concerns.
Why You Should Retain American International (AIG) Stock Now
by Zacks Equity Research
Rising premiums, cost control efforts, streamlining of operations and increasing rates poise American International (AIG) well for growth.
Erie Indemnity (ERIE) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Intercontinental (ICE), Freddie Mac Join to Enhance Loan Quality
by Zacks Equity Research
Intercontinental (ICE) and Freddie Mac collaborate to improve loan quality and reduce defects in the loan origination process.
Sun Life (SLF) Expands Family Leave Insurance Product in Florida
by Zacks Equity Research
Sun Life (SLF) bridges the gap of funding for small-size and mid-size firms, which enable them to provide paid family leave for their employees.
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD
Compelling Reasons to Hold on to Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) gains from strong segmental contribution, better rate hikes and solid growth in operating cash flows.
Recent Price Trend in Erie Indemnity (ERIE) is Your Friend, Here's Why
by Zacks Equity Research
Erie Indemnity (ERIE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
AON Acquires Humn.ai to Enhance Fleet & Mobility Offerings
by Zacks Equity Research
AON buys Humn.ai in a bid to provide innovative offerings for fleet and mobility clients.
Here's Why You Should Retain Arthur J. Gallagher (AJG) Stock
by Zacks Equity Research
Arthur J Gallagher (AJG) is poised to grow from the solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
3 Reasons Growth Investors Will Love Erie Indemnity (ERIE)
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Marsh & McLennan's (MMC) Mercer SelectRx to Lower Pharmacy Spend
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer launches a tech-enabled solution to generate higher cost savings for employees on specialty drugs and subsequently, drive its revenues.
All You Need to Know About Erie Indemnity (ERIE) Rating Upgrade to Buy
by Zacks Equity Research
Erie Indemnity (ERIE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Erie Indemnity (ERIE) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Erie Indemnity (ERIE) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD